Identifikasi Drug Related Problems (DRPs) pada Pasien Diabetes Melitus di RS Multazam Kota Gorontalo

Andi Makkulawu, Juliyanti Akuba


Diabetes Mellitus (DM) is a disease marked by high blood glucose level due t the body cannot release or use sufficient insulin. The management of DM medication therapy requires a long period of time, it can affect life quality of patient and can cause Drug Related Problems (DRPs). The DRPs is frequently occurred and causing less optimum medication. The research aimed to find out the type and percentage of DRPs based on anti-diabetes medication at diabetes mellitus patients with or without disease. This was descriptive research which was done retrospectively. The technique of determining sample/ data applied purposive sampling and obtained 24 samples that were appropriate with research inclusion criteria. The research finding showed that group of anti-diabetic medication ecompassed biguanide (metformin), sulfonylurea (glimepiride, gliclazide, gliquidone, and glibenclamide), inhibitor -glucosidase (acarbose, miglitol), thiazolidinedione (rosiglitazone, troglitazone, pioglitazone), meglitinide (repaglinide), and phenylalanine derivate (nateglinide), as well as insulin while based on identification of DRPs potential with following order category was namely right drug (drug without indication for 20%, indication without drug for 20%, combination of wrong drug for 6.67%, wrong drug selection for 6.67%), right dose category (too high dose for 13.33% and too low dose for 0%), and drug interaction category for 33.33%.


DRPs; Diabetes Mellitus; Multazam Hospital

Full Text:



. ADA (American Diabetes Association). 2009. Diabetes Care. Standart of Medical Care in Diabetes-2009. Volume 32, S13-S61

. ADA (American Diabetes Association). 2015. Standards Of Medical Care In Diabetes-2015. Beauregard St.

. American Diabetes Association (ADA). 2016. Standards of medical care in diabetes. American Diabetes Association: USA

. Carlisle, B.A., dan Koda-Kimble, M.A. Diabetes Mellitus in Young, L.Y. (Eds), 2005. Applied Therapeutics The Clinical Use of Drugs, 7th ed, Lippincott Williams and Wilkins

. Cipolle, J.R., Strand, L., dan Morley, C.P. 2008. Pharmaceutical Care Practice the Clinician’s Guide. Edisi ke 2. McGraw-Hill: New York-Toronto

. Dinkes Provinsi Gorontalo. 2018. Laporan Hasil Jumlah Penderita Diabetes Melitus. Dinkes Gorontalo: Kota Gorontalo

Lacy, C.F., Armstrong LL., Goldman M.P., dan Lance L. 2012. Drug Information Handbook. 17th Edition. Lexi Comp: New York

. Martindal. 2009. Pharmacoterapy Handbook 7th edition, Mc Graw Hill, New York. Maret: Surakarta.

. Pharmaceutical Care Network Europe. 2006. PCNE Classification For Drug Related Problem. Vol 51. PCNE: Europe

. PERKENI. 2011. Petunjuk Praktis Pengelolaan DM Tipe 2. Perkumpulan Endrokinologi: Jakarta

. RISKESDAS (Riset Kesehatan Dasar). 2007. Badan Penelitian dan Pengembangan Kesehatan, Departemen Kesehatan, Republik Indonesia: Jakarta

. Strand, L.M., Morley.1998. Drug Related Problem: Their Sructure and Function DICP Ann Pharmacotherapy. The Mc Grow Hill Companies

. Tatro. D.S. 2009. Drug Interaction Fact, The Authory on Drug Interaction, Wolters Kluwer HealthTjay, T.H., & Rahardja, K., 2007, Obat-Obat Penting (Khasiat Penggunaan dan Efek-Efek Sampingnya), Elex Media Komputindo Kelompok Kompas- Gramedia, Jakarta [14]. Tanto, Chris and Ni Made Hustini. 2014. Hipertensi Kapita Selekta Kedokteran Essentials of Medicine Edisi IV. Jakarta: Fakultas Kedokteran UI

. Trisnawati dan Setyorogo. 2013. Faktor Resiko Kejadian Diabetes Melitus Tipe II Di Puskesmas Kecamatan Cengkarang Jakarta Barat Tahun 2012.

. Wollen dan Bailey, 1988, Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin, Biochem Pharmacol.



  • There are currently no refbacks.

Copyright (c) 2022 Journal Syifa Sciences and Clinical Research

  Department of Pharmacy, Gorontalo State University
Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia

Creative Commons License

Journal Syifa Sciences and Clinical Research (JSSCR) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.